CHANGES to the Pharmaceutical Benefits Scheme (PBS) restrictions for growth hormone (GH) treatment (adult use), which set out the eligibility requirements for PBS subsidy, are being introduced on 01 Jan 2020.
The adult listing will be amended to improve clarity and access for patients with childhood onset growth hormone deficiency (CO-GHD) due to congenital, genetic or structural cause.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Dec 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Dec 19